-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Ibandronate sodium is a medication used to treat osteoporosis and other conditions that cause bone loss.
It is a type of bisphosphonate, a class of drugs that work by inhibiting the activity of cells called osteoclasts, which are responsible for breaking down bone tissue.
Ibandronate sodium is taken orally and is usually prescribed for the treatment of osteoporosis in postmenopausal women, as well as in men and women who are at high risk of fractures due to other conditions such as cancer or immobilization.
The chemical structure of ibandronate sodium is similar to that of other bisphosphonates, such as alendronate and risedronate.
It is a white or almost white, crystalline powder that is slightly soluble in water and slightly soluble in ethanol.
The molecular formula for ibandronate sodium is C16H19N3O7P3Na2N9 and its molecular weight is 742.
09 g/mol.
The dosage and administration of ibandronate sodium will depend on the condition being treated, as well as the individual patient.
In general, the recommended dose is one 50-mg tablet taken orally once a month, either on the first day of the month or at any time within the first six days of the month.
It is important to take ibandronate sodium after an overnight fast, and to avoid eating or drinking for at least 30 minutes after taking the medication.
Ibandronate sodium is usually well-tolerated, but it can cause side effects.
The most common side effects include nausea, vomiting, abdominal pain, and diarrhea.
These side effects are usually mild and go away on their own, but they may be severe in some cases.
More serious side effects are rare, but they can include osteonecrosis of the jaw, which is a condition in which the bone in the jaw dies and dissolves.
This side effect is more common in patients who have cancer and are taking ibandronate sodium to treat bone pain caused by the cancer.
Before taking ibandronate sodium, it is important to tell your doctor about any medical conditions you have, including any allergies, and any medications you are taking, including over-the-counter medications and supplements.
You should also inform your doctor if you have had osteoporosis for less than one year, if you have a history of esophagus or stomach problems, or if you are pregnant or breast-feeding.
In conclusion, ibandronate sodium is a medication used to treat osteoporosis and other conditions that cause bone loss.
It is a type of bisphosphonate that works by inhibiting the activity of osteoclasts, which are responsible for breaking down bone tissue.
It is taken orally and is usually prescribed for the treatment of osteoporosis in postmenopausal women, as well as in men and women who are at high risk of fractures due to other conditions such as cancer or immobilization.
While it is generally well-tolerated, it can cause side effects, including nausea, vomiting, abdominal pain, and diarrhea.
More serious side effects are rare, but they can include osteonecrosis of the jaw.
It is important to follow the dosage and administration instructions provided by your doctor and to inform your doctor of any medical conditions or medications you are taking before starting treatment with ibandronate sodium.